The 32 references in paper M. Statsenko E., M. Derevyanchenko V., N. Shilina N., M. Titarenko N., O. Pastukhova R., М. Стаценко Е., М. Деревянченко В., Н. Шилина Н., М. Титаренко Н., О. Пастухова Р. (2016) “Функциональное состояние почек у больных с сердечно-сосудистыми заболеваниями и ожирением // Renal function in patients with cardiovascular disease and obesity” / spz:neicon:nefr:y:2016:i:5:p:43-49

1
Tsigosa C, Hainerb V, Basdevantc A et al. for the Obesity Management Task Force of the European Association for the Study of Obesity Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity Facts 2008;1:106–116
(check this in PDF content)
2
World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000, 268 p
(check this in PDF content)
3
Заболотских ИБ, Лебединский КМ, Горобец ЕС и др. Клинические рекомендации Федерации анестезиологов и реаниматологов по периоперационному ведению больных с сопутствующим ожирением. Красноярск, 2013. 19 с. [Zabolotskih IB, Lebedinskij KM, Gorobec ES et al. Clinical guidelines Federation of Anesthesiologists and Resuscitation for preoperative management of patients with concomitant obesity. Krasnojarsk, 2013. 19 p.]
(check this in PDF content)
4
Hall JE, do Carmo JM, da Silva AA et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015 Mar 13;116(6):991-1006. doi: 10.1161/CIRCRESAHA.116.305697
(check this in PDF content)
5
Стаценко МЕ, Деревянченко МВ, Титаренко МН, Пастухова ОР. Кардиоренальные взаимоотношения у больных артериальной гипертензией в сочетании с сахарным диабетом 2 типа. Нефрология 2014; 18(5): 44-51 [Statsenko ME, Derevyanchenko MV, Titarenko MN, Pastukhova OR. Cardiorenal relationships in patients with arterial hypertension and type 2 diabetes. Nephrology 2014; 18 (5): 44-51]
(check this in PDF content)
6
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
(check this in PDF content)
7
Рабочая группа Российского кардиологического общества, Научного общества нефрологов России, Российской ассоциации эндокринологов, Российского медицинского общества по артериальной гипертонии, Национального общества по изучению атеросклероза, Российского научного медицинского общества терапевтов. Национальные рекомендации. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции. Российский кардиологический журнал 2014;
(check this in PDF content)
8
112): 7-37 [Russian National Guidelines. Cardiovascular risk and chronic kidney disease: cardio nephroprotection strategy. Russian Journal of Cardiology 2014; 8 (112): 7-37] 8. Ройтберг ГЕ, Дорош ЖВ, Шархун OO и др. Возможности применения нового метаболического индекса при оценке инсулинорезистентности в клинической практике. РФК 2014;10(3):264-274 [Roytberg GE, Dorosh JV, Sharhun OO et al. New metabolic index use potentialities in evaluation of insulin resistance in clinical practice. RPhC 2014;10(3):264-274].
(check this in PDF content)
9
Стаценко МЕ, Деревянченко МВ, Пастухова ОР. Влияние комбинированной антигипертензивной терапии на суточный профиль артериального давления и показатели метаболизма у больных сахарным диабетом 2 типа Кардиология 2014; 54(11):20-24 [Statsenko ME, Derevyanchenko MV, Pastuhova OR. Effect of combined antihypertensive therapy on circadian blood pressure profile and metabolic parameters in patients with type 2 diabetes Cardiology 2014; 54 (11): 20-24]
(check this in PDF content)
10
Стаценко МЕ, Деревянченко МВ. Кардионефропротекция – важнейшая задача антигипертензивной терапии у больных сахарным диабетом 2 типа. Кардиология 2015;55(8):43-48 [Statsenko ME, Derevyanchenko MV. Cardio-nephroprotection is the most important task of antihypertensive therapy in patients with type 2 diabetes. Cardiology 2015; 55 (8): 43-48]
(check this in PDF content)
11
Стаценко МЕ, Деревянченко МВ. Метаболические эффекты комбинированной антигипертензивной терапии у больных сахарным диабетом 2 типа. РФК 2015;11(1):36-39 [Statsenko ME, Derevyanchenko MV. Metabolic effects of combined antihypertensive therapy in patients with type 2 diabetes. RFC 2015; 11 (1): 36-39]
(check this in PDF content)
12
Hall JE, da Silva AA, do Carmo JM et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 2010;285:17271–17276
(check this in PDF content)
13
Vliet BN, Hall JE, Mizelle HL et al. Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 1995;269:H629–H637
(check this in PDF content)
14
Lohmeier TE, Iliescu R. The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep 2013;15:409–416
(check this in PDF content)
15
Freedman D, Ron E, Ballard-Barbash R. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 2006; 30: 822-829
(check this in PDF content)
16
Guh D, Zhang W, Bansback N. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88
(check this in PDF content)
17
Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009; 106: 641-648
(check this in PDF content)
18
Bellamy M, Struys M. Anaesthesia for the Overweight and Obese Patient. 1. Oxford: Oxford University Press; 2007
(check this in PDF content)
19
Bouchi R, Takeuchi T, Akihisa M et al. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2015) 14:136. DOI 10.1186/s12933-015-0302-4
(check this in PDF content)
20
Després JP, Lemieux S, Lamarche B et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes Relat Metab Disord. 1995;19(Suppl 1):S76–86.
(check this in PDF content)
21
Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39–48
(check this in PDF content)
22
ois NE, Bartels ED, Hunter I et al. Natriuretic peptides in cardiometabolic regulation and disease. Nat Rev Cardiol 2014;11:403–412
(check this in PDF content)
23
Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625–633
(check this in PDF content)
24
Hall JE, Crook ED, Jones DW et al. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 2002;324:127–137
(check this in PDF content)
25
Hall ME, do Carmo JM, da Silva AA et al. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 2014;7:75–88
(check this in PDF content)
26
Dwyer TM, Bigler SA, Moore NA et al. The altered structure of renal papillary outflow tracts in obesity. Ultrastruct Pathol 2000;24:251–257
(check this in PDF content)
27
Dwyer TM, Banks SA, Alonso-Galicia M et al. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int 2000;58:721–729
(check this in PDF content)
28
Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner renal medulla of obese dogs. Hypertension 1995;25:888–892
(check this in PDF content)
29
Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci 1999;892:91–107
(check this in PDF content)
30
Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004;286:R803– R813
(check this in PDF content)
31
Yusuf S, Hawken S, Ounpuu S et al. INTERHEART Study Investiga-tors, et al. Obesity and the risk of myocardial infarction in 27,000 partici-pants from 52 countries: a case-control study. Lancet 2005; 366:1640–1649
(check this in PDF content)
32
Britton KA, Massaro JM, Murabito JM et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013;62:921–925 Сведения об авторах: Проф. Стаценко Михаил Евгеньевич
(check this in PDF content)